The protein encoded by this proto-oncogene is a member of the Dbl family of guanine nucleotide exchange factors (GEF) for the Rho family of GTP binding proteins. The protein is important in hematopoiesis, playing a role in T-cell and B-cell development and activation. This particular GEF has been identified as the specific binding partner of Nef proteins from HIV-1. Coexpression and binding of these partners initiates profound morphological changes, cytoskeletal rearrangements and the JNK/SAPK signaling cascade, leading to increased levels of viral transcription and replication.
Target |
VAV1 |
Reactivity |
Human |
Host |
Mouse |
Clonality |
Monoclonal |
Tested Applications |
ELISA, WB, FCM |
Recommended dilutions |
ELISA: 1/10000, WB: 1/250, FCM: 1/200 - 1/400. Optimal dilutions/concentrations should be determined by the end user. |
Immunogen |
Purified recombinant fragment of human VAV1 (AA: 121-324) expressed in E. Coli. |
Purification |
Purified antibody |
Isotype |
IgG1 |
Conjugation |
Unconjugated |
Storage |
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
Molecular Weight |
98.3 kDa |
Swiss Prot |
P15498
|
GeneID |
7409
|
Gene Symbol |
VAV1 |
OMIM |
164875
|
HGNC |
12657 |
Ensembl |
ENSG00000141968 |
Concentration |
1.0 mg/ml |
Buffer |
PBS with 0.05% sodium azide and 0.5% protein stabilizer. |
UNSPSC Code |
12352203 |
Availability |
Shipped within 5-10 working days. |
Note |
This product is for research use only. |